31 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
EFFECTS AND ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Loop #Thiazide #CHF ... #Cardiology #Management
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
American College of Cardiology ... Practice Guidelines and ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
initial dosing and ... INR targets #pharmacology ... #medications #drugs ... #cardiology #warfarin ... #management
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... pharmacology ... #pharmacology # ... inopressors #diagnosis #management ... #comparison #table
Medications Used in Congestive Heart Failure

In CHF, the heart is failing as a pump; cardiac output
congestion the lungs and ... sympathetic system and ... failure is chronic Drug ... #Pharmacology #CHF ... #HeartFailure #Cardiology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table ... #decisionaid #cardiology
Atrial Fibrillation Overview

Symptoms:
Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

1. Why?
Cardiac:
• Valvular heart disease
•
Decompensated HF ... Pulmonary disease • Drugs ... #Fibrillation #Cardiology ... #Management #Algorithm
Algorithm for the Evaluation and Management of Suspected Congenital Heart Disease in Neonates

Neonates with undiagnosed congenital
Algorithm for the ... Management of Suspected ... #HeartDisease #Algorithm ... Neonates #Neonatal #Peds ... #Pediatrics #Cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
and recommended ... circulatory support; and ... #CHF #Congestive ... Stages #ACCAHA #Algorithm ... #Management #Cardiology